In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs

被引:31
作者
Kunze, Annett [1 ,2 ]
Huwyler, Joerg [2 ]
Poller, Birk [1 ]
Gutmann, Heike [1 ]
Camenisch, Gian [1 ]
机构
[1] Novartis Inst BioMed Res, Drug Drug Interact Sect, Div Drug Metab & Pharmacokinet, CH-4056 Basel, Switzerland
[2] Univ Basel, Div Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
关键词
in vitro-in vivo correlations (IVIVC); renal clearance; renal reabsorption; permeability; drug transport; in vitro models; membrane transport; pharmacokinetics; LLC-PK1 cell line; clearance prediction; TRANSCELLULAR TRANSPORT; MEMBRANE TRANSPORTERS; LLC-PK1; KIDNEY; PARAMETERS; METABOLISM; MECHANISMS; MONOLAYERS; EXPRESSION; MODEL;
D O I
10.1002/jps.23851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to predict the renal organ clearance as the net result of glomerular filtration, tubular secretion, and tubular reabsorption. In this study, we measured in LLC-PK1 cells the transport of 20 compounds that cover all four classes of the Biopharmaceutical Drug Disposition System. These data were incorporated into a novel kidney model to predict all renal clearance processes in human. We showed that filtration and secretion were main contributors to the renal organ clearance for all compounds, whereas reabsorption was predominant for compounds assigned to classes 1 and 2. Our results suggest that anionic drugs were not significantly secreted in LLC-PK1 cells, resulting in under-predicted clearances. When all study compounds were included a high overall correlation between the reported and predicted renal organ clearances was obtained (R-2 = 0.83). The prediction accuracy in terms of percentage within twofold and threefold error was 70% and 95%, respectively. In conclusion, our novel IVIVE method allowed to predict the human renal organ clearance and the contribution of each underlying process. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 50 条
  • [31] In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A
    Polasek, Thomas M.
    Sadagopal, Janani S.
    Elliot, David J.
    Miners, John O.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (03) : 275 - 283
  • [32] In Vivo-to-In Vitro Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach
    Kumar, Aditya R.
    Prasad, Bhagwat
    Bhatt, Deepak Kumar
    Mathialagan, Sumathy
    Varma, Manthena V. S.
    Unadkat, Jashvant D.
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (06) : 470 - 478
  • [33] Permeability characteristics of Calu-3 human bronchial epithelial cells:: In vitro-in vivo correlation to predict lung absorption in rats
    Mathias, NR
    Timoszyk, J
    Stetsko, PI
    Megill, JR
    Smith, RL
    Wall, DA
    JOURNAL OF DRUG TARGETING, 2002, 10 (01) : 31 - 40
  • [34] Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance
    De Bruyn, Tom
    Ufuk, Ayse
    Cantrill, Carina
    Kosa, Rachel E.
    Bi, Yi-an
    Niosi, Mark
    Modi, Sweta
    Rodrigues, A. David
    Tremaine, Larry M.
    Varma, Manthena V. S.
    Galetin, Aleksandra
    Houston, J. Brian
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (07) : 989 - 1000
  • [35] Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discovery
    Bell, Leslie C.
    Wang, Jianling
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (09) : 1131 - 1155
  • [36] Cellular Metabolism in High-Throughput In Vitro Reporter Gene Assays and Implications for the Quantitative In Vitro-In Vivo Extrapolation
    Fischer, Fabian C.
    Abele, Cedric
    Henneberger, Luise
    Kluver, Nils
    Konig, Maria
    Muhlenbrink, Marie
    Schlichting, Rita
    Escher, Beate, I
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (07) : 1770 - 1779
  • [37] Development of Mechanistic In Vitro-In Vivo Extrapolation to Support Bioequivalence Assessment of Long-Acting Injectables
    Silva, Daniela Amaral
    Le Merdy, Maxime
    Alam, Khondoker Dedarul
    Wang, Yan
    Bao, Quanying
    Malavia, Nilesh
    Burgess, Diane
    Lukacova, Viera
    PHARMACEUTICS, 2024, 16 (04)
  • [38] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data
    Scotcher, Daniel
    Jones, Christopher
    Posada, Maria
    Rostami-Hodjegan, Amin
    Galetin, Aleksandra
    AAPS JOURNAL, 2016, 18 (05): : 1067 - 1081
  • [39] Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 50 - 61
  • [40] How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective
    Wang, Lei
    Chiang, ChienWei
    Liang, Hong
    Wu, Hengyi
    Feng, Weixing
    Quinney, Sara K.
    Li, Jin
    Li, Lang
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015